EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Nature Medicine

ISSN 1078-8956 · Springer Science and Business Media LLC

Neueste Artikel

  1. Normalized membrane ratio of TROP2 as a predictor of clinical outcomes with datopotamab deruxtecan in non-small-cell lung cancer

    Marina C. Garassino, Myung-Ju Ahn, Markus Schick, Ansh Kapil, Luis Paz-Ares, Aaron Lisberg, Melissa L. Johnson, Maurice Pérol, Toshio Shimizu, Rebecca Heist, Alexander Spira, Isamu Okamoto, Nicolas Girard, Robin Cornelissen, Elvire Pons-Tostivint, Min Hee Hong, Ricardo Zwirtes, Rachel Chiaverelli, Marlon Rebelatto, Matthew Sung, Chuyu Deng, James Harper, Danielle Carroll, Hadassah Sade, Jacob Sands

    Erschienen: 2026-11-11DOI: 10.1038/s41591-026-04716-9

  2. Blood-based RNA biomarker for the early detection of ovarian cancer

    Jochen Wilhelm, Amit Kumar, Hitesh Vasiyani, Narsimha Mamidi, Zhaoyu Sun, Aenya Gogna, Praveen Bhoopathi, Keshav C. Gogna, Chelsea Salyer, Amy Lu, Kranthi Kumar Chougoni, Ava N. Gardner, Andrew S. Poklepovic, Masaki Nagane, Kumari S. Shree, Emad A. Rakha, Karuppaiyah Selvendiran, George L. Maxwell, Jamie N. Bakkum-Gamez, Shariska Petersen Harrington, Elnaz Abbasi Farid, Nadia Traficante, David Bowtell, Christopher D. Collier, Rebecca Z. Drexler, Christine Kramer, Mary M. Mullen, Alexandar Tzankov, Kirsten D. Mertz, Jun Watanabe, Shimpei Nagai, Tatsuyuki Chiyoda, Wataru Yamagami, Kenta Masuda, Elena Garre, Göran Landberg, David L. Kolin, Calla O’Connor, Sarah A. Ackroyd, Bodour Salhia

    Erschienen: 2026-11-10DOI: 10.1038/s41591-026-04732-9

  3. An ulcerative colitis taxonomy defined by individual patient-reported response trajectories

    Stefan Schreiber, Vijay Yajnik, Cenfu Wei, Maria D. Paraskevopoulou, Saman Farahmand, Jie Cheng, Katherine Simpson, Zitong Lin, Christian Agboton, Pratik Panchal, Banishree Saha, Ninfa Candela, Joshua Brown, Isabella Peshek, Frida Chavez, Libeth Rosas, Alan Robinson, Gursimran Singh Kochhar, Aakash Desai, Franziska Kimmig, Philip Rosenstiel, Paresh Thakker, Parambir S. Dulai

    Erschienen: 2026-11-09DOI: 10.1038/s41591-026-04741-8

  4. Perioperative ivonescimab with or without chemotherapy in resectable non-small cell lung cancer: a phase 2 trial

    Xiaoliang Zhao, Bin Zhang, Chenguang Li, Lianmin Zhang, Meng Wang, Ziqiang Tian, Shengguang Wang, Qiang Zhang, Huilai Lv, Chong Pang, Shiwang Wen, Xiaofei Wang, Wei Wei, Yu Zhang, Wuhao Huang, Jianquan Zhu, Yue Li, Chen Chen, Yao Tang, Bin Jia, Hua Zhang, Hui Chen, Sha Wang, Jiangyan Zhang, Wenting Li, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Zhenfa Zhang, Dongsheng Yue, Changli Wang

    Erschienen: 2026-11-04DOI: 10.1038/s41591-026-04745-4

  5. A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial

    Doris M. Ponce, Zachariah DeFilipp, Christopher B. Ford, Bina Tejura, Mary-Jane Lombardo, David I. Lichter, Meghan Chafee, Satyajit Kosuri, Nandita Khera, Hemant S. Murthy, Karamjeet S. Sandhu, David N. Fredricks, Tessa Andermann, Rajneesh Nath, Kelly Brady, Brooke R. Hasson, Emily Walsh, Nathan Hicks, Jonathan U. Peled, Lisa von Moltke, Matthew R. Henn, Marcel R. M. van den Brink, Dennis M. Walling, William J. Hogan, Nosha Farhadfar, Steven Tsai, Zeina Al-Mansour, Chirag Patel, Swarna Pandian, Kankana Bardhan, Sean Sykes

    Erschienen: 2026-11-03DOI: 10.1038/s41591-026-04686-y

  6. Regulatable membrane-bound IL-15 engineered TIL cell therapy for immune checkpoint inhibitor-resistant advanced melanoma: pooled analysis of phase 1 and 1/2 trials

    Rodabe N. Amaria, Jason A. Chesney, Allison S. Betof, Gino K. In, Alexander N. Shoushtari, Tirrell T. Johnson, Omid Hamid, Yazan Samhouri, Michael A. Davies, Hussein A. Tawbi, Isabella C. Glitza Oliva, Bulent Arman Aksoy, Amanda M. Kelly, Raina Duan, Prakash Prabhakar, Giridharan Ramsingh, Madan Jagasia, Parameswaran Hari

    Erschienen: 2026-11-03DOI: 10.1038/s41591-026-04743-6

  7. Publisher Correction: Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy

    Florence Magrangeas, Mia Cherkaoui, Victor Bessonneau-Gaborit, Jennifer Derrien, Céline Chevalier, Catherine Guérin-Charbonnel, Benjamin Diamond, Mehmet Kemal Samur, Cyrille Hulin, Denis Caillot, Lionel Karlin, Bertrand Arnulf, Ola Landgren, Nikhil C. Munshi, Hervé Avet-Loiseau, Ludovic Martinet, Jill Corre, Aurore Perrot, Philippe Moreau, Cyrille Touzeau, Stéphane Minvielle, Eric Letouzé

    Erschienen: 2026-11-03DOI: 10.1038/s41591-026-04792-x

  8. Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial

    Filippo Ghelardi, Margherita Ambrosini, Alessandra Raimondi, Andrei Tyshevich, Federica Palermo, Francesca Bergamo, Vincenzo Nasca, Paolo Manca, Ilaria Mulas, Lisa Derosa, Gina Brown, Claudia Chiodoni, Massimo Di Maio, Samantha Di Donato, Anna Chiaramonte, Lorenzo Castagnoli, Stephanie Ni, Darryl Nousome, Erik Spickard, Antony Tin, Robert Lentz, Adham Jurdi, Giovanna Sabella, Daniele Spada, Stefano Tamberi, Alessandro Passardi, Federica Morano, Emiliano Tamburini, Chiara Rossi, Luca Azzolin, Francesco Cambuli, Antonia Martinetti, Elisa Sottotetti, Andrew Allan Almonte, Valerio Iebba, Chiara Ratti, Riccardo Cerantola, Özlem Kutlu, Eleonora Cristarella, Serenella M. Pupa

    Erschienen: 2026-11-02DOI: 10.1038/s41591-026-04710-1

  9. Global, regional and national burden of cervical cancer in 1990–2023 with forecasts to 2050: a Global Burden of Disease study

    Natalie Pritchett, Miranda L. May, Jonathan M. Kocarnik, Kayleigh Bhangdia, Louise Penberthy, Bhoomadevi A, Hasan Aalruz, Hazim S. Ababneh, Hedayat Abbastabar, Samar Abd ElHafeez, Ashraf Nabiel Abdalla, Mohammed Altigani Abdalla, Nadin M. I. Abdel Razeq, Reda Abdel-Hameed, Wael M. Abdel-Rahman, Wakgari Mosisa Abdisa, Ali Abdolizadeh, Meriem Abdoun, Abdullah, Mesfin Abebe, Yonas Tarefa Abebe, Habtamu Abebe Getahun, Armita Abedi, Yirgalem Abere, Alemwork Abie, Olifan Zewdie Abil, Olumide Abiodun, Richard Gyan Aboagye, Amr Selim Abu Lila, Mohammad H. Abuadas, Bilyaminu Abubakar, Eman Abu-Gharbieh, Salahdein Aburuz, Ahmed Abu-Zaid, Juan M. Acuna, Lisa C. Adams, Aishah Fadila Adamu, Lawan Hassan Adamu, Isaac Yeboah Addo, Clement Adebamowo

    Erschienen: 2026-11-02DOI: 10.1038/s41591-026-04729-4

  10. Climate change threatens malaria elimination in the Asia Pacific

    Kimberly Fornace, Phone Si Hein, Bimandra Djaafara, Md. Noor Ashad-Uz-Zaman, Chia-Chen Chang, Iqbal Elyazar, Clariza D. Fernandez, Joyce Hu, Rahmad Isa, Jacob Kisomb, Jun-Sik Lim, Nwe Ni Linn, Alison Low, Edgar Manrique, Richard Maude, Ian Christopher N. Rocha, Chawarat Rotejanaprasert, Josephine So-onguku, Dedy Supriyanto, Vilaphanh Yengmala, Ming Keong Wan, Shobiechah Aldillah Wulandhari, Natasha Howard, Leo Braack, Swapnil Mishra, Muhammad Mukhtar

    Erschienen: 2026-10-30DOI: 10.1038/s41591-026-04722-x

  11. A clinical multimodal vision language foundation model with fine-grain explainability

    Yang Bai, Haoran Cheng, Yang Zhou, Jun Zhou, Arun Thirunavukarasu, Yuhe Ke, Jie Yao, Kanae Fukutsu, Chrystie Wan Ning Quek, Ashley Shuen Ying Hong, Laura Gutierrez, Alessandro Berni, Zhen Ling Teo, Darren Shu Jeng Ting, Brian T. Soetikno, Christopher S. Nielsen, Tobias Elze, Zengxiang Li, Sumit Sharma, Nicholas Ruthmann, Le Dinh Linh, Hiok Hong Chan, Victor Koh, Marcus Tan, Kelvin Z. Li, Leonard Yip, Ching Yu Cheng, Yih Chung Tham, Gavin Siew Wei Tan, Leopold Schmetterer, Rae-Young Kim, Damon Wong, Marcus Ang, Rahat Hussain, Jodhbir S. Mehta, Tin Aung, Lionel Tim-Ee Cheng, Nguyen Tuan Anh Tran, Chee Leong Cheng, Tien Yin Wong

    Erschienen: 2026-10-29DOI: 10.1038/s41591-026-04655-5

Jahrgänge

2026 · 6172025 · 7512024 · 7252023 · 6182022 · 5632021 · 5062020 · 4952019 · 4372018 · 3612017 · 2612016 · 2912015 · 3062014 · 4172013 · 5112012 · 5822011 · 6162010 · 5702009 · 4682008 · 4332007 · 4582006 · 4942005 · 4652004 · 5222003 · 5112002 · 5042001 · 5112000 · 5531999 · 5761998 · 6081997 · 5791996 · 6191995 · 603

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.